Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2021 Jan 15;203(2):245-249.
doi: 10.1164/rccm.202007-2638LE.

Risk Factors for Mortality after COVID-19 in Patients with Preexisting Interstitial Lung Disease

Laure Gallay  1 , Yurdagül Uzunhan  2 , Raphael Borie  3 , Romain Lazor  4 , Pierre Rigaud  5 , Sylvain Marchand-Adam  6 , Sandrine Hirschi  7 , Dominique Israel-Biet  8 , Victor Valentin  9 , Vincent Cottin  1
Affiliations
Observational Study

Risk Factors for Mortality after COVID-19 in Patients with Preexisting Interstitial Lung Disease

Laure Gallay et al. Am J Respir Crit Care Med. .
No abstract available

PubMed Disclaimer

References

    1. Wong AW, Fidler L, Marcoux V, Johannson KA, Assayag D, Fisher JH, et al. Practical considerations for the diagnosis and treatment of fibrotic interstitial lung disease during the coronavirus disease 2019 pandemic. Chest. 2020;158:1069–1078. - PMC - PubMed
    1. George PM, Wells AU, Jenkins RG. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy. Lancet Respir Med. 2020;8:807–815. - PMC - PubMed
    1. Esposito AJ, Menon AA, Ghosh AJ, Putman RK, Fredenburgh LE, El-Chemaly SY, et al. Increased odds of death for patients with interstitial lung disease and COVID-19: a case-control study Am J Respir Crit Care MedIn press) - PMC - PubMed
    1. Drake TM, Docherty AB, Harrison EM, Quint JK, Adamali H, Agnew S, et al. ISARIC4C Investigators. Outcome of hospitalization for COVID-19 in patients with interstitial lung disease: an international multicenter study. Am J Respir Crit Care Med. 2020;202:1656–1665. - PMC - PubMed
    1. Emmi G, Bettiol A, Mattioli I, Silvestri E, Di Scala G, Urban ML, et al. SARS-CoV-2 infection among patients with systemic autoimmune diseases. Autoimmun Rev. 2020;19:102575. - PMC - PubMed